Rosuvastatin calcium and process for producing intermediate thereof
US-2024360086-A1 · Oct 31, 2024 · US
US12522852B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12522852-B2 |
| Application number | US-202017910787-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 26, 2020 |
| Priority date | Mar 18, 2020 |
| Publication date | Jan 13, 2026 |
| Grant date | Jan 13, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention discloses a method for preparing L-glufosinate ammonium by biological enzymatic de-racemization, a glufosinate ammonium dehydrogenase mutant and a use thereof. The method for preparing L-glufosinate ammonium by biological enzymatic de-racemization includes catalyzing D,L-glufosinate ammonium as a raw material by a multi-enzyme catalysis system to obtain L-glufosinate ammonium. The enzyme catalysis system includes D-amino acid oxidase for catalyzing D-glufosinate ammonium in the D,L-glufosinate ammonium to 2-carbonyl-4-[hydroxy(methyl)phosphonyl]butanoic acid, and a glufosinate ammonium dehydrogenase mutant for catalytically reducing 2-carbonyl-4-[hydroxy(methyl)phosphonyl]butanoic acid to L-glufosinate ammonium. The glufosinate ammonium dehydrogenase mutant is obtained by mutation of glufosinate-ammonium dehydrogenase in wild fungi Thiopseudomonas denitrificans at a mutation site of V377S. The glufosinate ammonium dehydrogenase mutant in the present invention has better catalytic efficiency. When racemic D, L-glufosinate ammonium is used as a substrate for a catalytic reaction, the conversion rate is much higher than the conversion rate of a wild-type enzyme, and the yield of 2-carbonyl-4-[hydroxy(methyl)phosphonyl]butanoic acid (PPO for short) is also greatly improved.
Opening claim text (preview).
The invention claimed is: 1 . A glufosinate ammonium dehydrogenase mutant that comprises SEQ ID NO: 4. 2 . A gene for coding the glufosinate ammonium dehydrogenase mutant according to claim 1 , wherein the gene has a nucleotide sequence comprising SEQ ID NO: 3. 3 . A recombinant bacterium comprising the gene according to claim 2 . 4 . A method for preparing L-glufosinate ammonium by biological enzymatic de-racemization, comprising catalyzing D,L-glufosinate ammonium as a raw material by a multi-enzyme catalysis system to obtain L-glufosinate ammonium, wherein the enzyme catalysis system comprises D-amino acid oxidase for catalyzing D-glufosinate ammonium in the D,L-glufosinate ammonium to 2-carbonyl-4-[hydroxy(methyl)phosphonyl]butanoic acid, and a glufosinate ammonium dehydrogenase mutant for catalytically reducing 2-carbonyl-4-[hydroxy (methyl)phosphonyl] butanoic acid to L-glufosinate ammonium, and the glufosinate ammonium dehydrogenase mutant comprises SEQ ID NO: 4. 5 . The method according to claim 4 , wherein an amino acid sequence of the D-amino acid oxidase comprises SEQ ID NO: 9. 6 . The method according to claim 4 , wherein the enzyme catalysis system further comprises catalase for removing a byproduct including hydrogen peroxide. 7 . The method according to claim 4 , wherein the enzyme catalysis system further comprises a coenzyme cycling system, and the coenzyme cycling system is at least one of the following: (1) a formate dehydrogenase coenzyme cycling system comprising a formate dehydrogenase, formate and a coenzyme; (2) a glucose dehydrogenase coenzyme cycling system comprising a glucose dehydrogenase, glucose and a coenzyme; and (3) an alcohol dehydrogenase coenzyme cycling system comprising an alcohol dehydrogenase, isopropanol and a coenzyme. 8 . The method according to claim 7 , wherein an amino acid sequence of the formate dehydrogenase comprises SEQ ID NO: 13; an amino acid sequence of the glucose dehydrogenase comprises SEQ ID NO: 11; or and an amino acid sequence of the alcohol dehydrogenase comprises SEQ ID NO: 15.
Catalase (1.11.1.6) · CPC title
D-Amino-acid oxidase (1.4.3.3) · CPC title
Formate dehydrogenase (1.2.1.2) · CPC title
Glucose dehydrogenase (acceptor) (1.1.99.10) · CPC title
Alcohol dehydrogenase (1.1.1.1) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.